| Bioactivity | SYNV-cyclo(CGGYF) TFA is a Staphylococcus hominis (S. hominis) C5 autoinducing peptide. SYNV-cyclo(CGGYF) TFA inhibits S. aureus activity. SYNV-cyclo(CGGYF) TFA has the potential for the research of S. aureus-mediated epithelial damage and inflammation[1]. |
| Name | SYNV-cyclo(CGGYF) TFA |
| Sequence | Ser-Tyr-Asn-Val-cyclo(Cys-Gly-Gly-Tyr-Phe) |
| Shortening | SYNV-cyclo(CGGYF) |
| Formula | C48H59F3N10O15S |
| Molar Mass | 1105.10 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Williams MR, et al. Quorum sensing between bacterial species on the skin protects against epidermal injury in atopic dermatitis. Sci Transl Med. 2019 May 1;11(490):eaat8329. |
SYNV-cyclo(CGGYF) TFA
CAS: F: C48H59F3N10O15S W: 1105.10
SYNV-cyclo(CGGYF) TFA is a Staphylococcus hominis (S. hominis) C5 autoinducing peptide. SYNV-cyclo(CGGYF) TFA inhibits S
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.